Wald Outreach for Wellness: Blood Pressure Outreach

Hypertension Clinical Trial

— WOW  

Official title:

Wald Outreach for Wellness

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT04286568
• Other study ID #: IRB00243167
• Status: Withdrawn
• Phase: N/A
• Start date: February 2023
• Est. completion date: February 2024

Study information

• Verified date: August 2022
• Source: Johns Hopkins University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The Wald Outreach Center will partner with Medicine for the Greater Good (MGG) to implement this pilot project called Wald Outreach for Wellness (WOW), a blood pressure outreach wellness intervention in a retail setting.

Description:

WOW aims to provide community members with a digital blood pressure monitor, health education, and health care navigation as practical strategies to improve community members' management of pre-hypertension, and to reduce associated burdens and risks related to hypertension health disparities. This approach to reaching populations who use retail settings has the potential to implement a health promotion and wellness strategy aimed at populations with increased risk for hypertension related health disparities. The outreach strategy is aimed at reaching community members where community members gather for health care, provide the community members with practical, low-cost strategies for promoting health and wellness, increase community members' knowledge in hypertension management, help the community members navigate health care options and get the community members engaged in a medical home thereby reducing the burdens of hypertension health disparities. This research is important to continue to assess the best ways to reach and reduce hypertension health disparities in underserved communities with limited access to health care.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: February 2024
• Est. primary completion date: February 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Community residents who participate in Day at the Market
• Adult individuals 18 years and older whose recorded BP reading is within the pre-hypertensive range 120-139 systolic; 80-89 diastolic
• Able to read and understand English

Exclusion Criteria:

• 17 years or younger
• BP reading above pre-hypertensive range
• Unable to read and understand English

Related Conditions & MeSH terms

• Hypertension
• Pre-hypertension
• Prehypertension

Intervention

Behavioral:
• WOW Intervention
Health education and coaching, health care navigation,

Locations

Country	Name	City	State
United States	Johns Hopkins University School of Nursing	Baltimore	Maryland

Sponsors (1)

Lead Sponsor	Collaborator
Johns Hopkins University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in actions to control hypertension as assessed by the Behavioral Risk Factor Surveillance System Module 7	Change in yes/no answers assessed by Behavioral Risk Factor Surveillance System (BRFSS) Module 7. 10 questions graded by yes/no response.	Assessed at baseline, 6 weeks and 12 weeks
Primary	Change in blood pressure	Change in blood pressure (BP) measured in mmHg.	Assessed at baseline and every 2 weeks, up to 3 months
Secondary	Change in usage of BP monitor	Change in usage of blood pressure monitor assessed by number of BP readings done by participants.	Assessed at baseline and every 2 weeks, up to 3 months
Secondary	Change in knowledge of the signs and symptoms of a heart attack and stroke as assessed by BRFSS Module 8	Change in knowledge (yes/no responses) of signs and symptoms of stroke/heart attack as assessed by BRFSS Module 8. 13 Questions graded by yes/no.	Assessed at baseline, 6 weeks and 12 weeks
Secondary	Change in engagement with healthcare provider as assessed by BRFSS Section 3	Change in engagement with healthcare provider/medical home as assessed by BRFSS Section 3. 3 questions graded by yes/no.	Assessed at baseline, 6 weeks and 12 weeks